In an ICC dispute, CRA was retained by respondent regarding the renegotiation of price in a supply agreement for a pharmaceutical sold in Japan. In expert reports and testimony, CRA evaluated the adequacy of returns made by respondent with request to development and commercialization of the product for the Japanese market.
Investment treaty disputes in the life sciences industry
In its global scale and economic impact, the life sciences industry presents unique considerations for investment treaty arbitrations. Recently, the COVID-19...